02137.HK
Brii Biosciences Limited
HKSE · Healthcare · Biotechnology · CN
HKD 0.98
+1.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.27x
- Price / sales
- 32.88x
- Price / cash flow
- -2.55x
Enterprise value
- Enterprise value
- -HKD 1.4B
- EV / sales
- -66.44x
- EV / EBITDA
- 4.61x
- EV / EBIT
- 4.49x
- Market cap
- HKD 707.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026